A Novel Use of Romiplostim for SARS-CoV-2-induced Thrombocytopenia

被引:4
|
作者
Schneider, Coursen W. [1 ]
Penney, Scott W. [2 ]
Helfrich, Alison M. [3 ]
Hartman, Kip R. [2 ]
Lieuw, Kenneth [2 ]
机构
[1] Walter Reed Natl Mil Med Ctr, Dept Pediat, Bethesda, MD USA
[2] Walter Reed Natl Mil Med Ctr, Dept Pediat Hematol Oncol, 4493 North Palmer Rd, Bethesda, MD 20889 USA
[3] Walter Reed Natl Mil Med Ctr, Dept Pediat Infect Dis, Bethesda, MD USA
关键词
coronavirus disease of 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); thrombocytopenia; thrombopoetin receptor agonist; IMMUNE THROMBOCYTOPENIA; DOUBLE-BLIND; CHILDREN; PHASE-3;
D O I
10.1097/MPH.0000000000001961
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The literature regarding coronavirus disease of 2019 (COVID-19) infection in pediatrics indicates that children have less severe clinical presentations and lower mortality rates. There remains limited data regarding hematologic sequelae in pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Romiplostim has shown a platelet response in pediatric patients with chronic immune thrombocytopenic purpura, and eltrombopag is proven to increase platelet counts in patients with inherited thrombocytopenia. We review SARS-CoV-2-associated thrombocytopenia and present a pediatric patient with acute on chronic thrombocytopenia in the setting of COVID-19 with subsequent platelet recovery using romiplostim.
引用
收藏
页码:E788 / E790
页数:3
相关论文
共 50 条
  • [41] Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies
    Cortese, Mirko
    Lee, Ji-Young
    Cerikan, Berati
    Neufeldt, Christopher J.
    Oorschot, Viola Mj
    Koehrer, Sebastian
    Hennies, Julian
    Schieber, Nicole L.
    Ronchi, Paolo
    Mizzon, Giulia
    Romero-Brey, Ines
    Santarella-Mellwig, Rachel
    Schorb, Martin
    Boermel, Mandy
    Mocaer, Karel
    Beckwith, Marianne S.
    Templin, Rachel M.
    Gross, Viktoriia
    Pape, Constantin
    Tischer, Christian
    Frankish, Jamie
    Horvat, Natalie K.
    Laketa, Vibor
    Stanifer, Megan
    Boulant, Steeve
    Ruggieri, Alessia
    Chatel-Chaix, Laurent
    Schwab, Yannick
    Bartenschlager, Ralf
    CELL HOST & MICROBE, 2020, 28 (06) : 853 - +
  • [42] SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target
    Giovannoni, Federico
    Quintana, Francisco J.
    CELL RESEARCH, 2021, 31 (01) : 1 - 2
  • [43] Neutropenic Fever in a Patient With SARS-CoV-2-Induced Hemophagocytic Lymphohistiocytosis (HLH)
    Runge, Elliot
    Stoffel, Steven
    Rendo, Matthew
    Beeler, Bradley W.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [44] Neurophysiological Aspects in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
    Vecchio, Eleonora
    Gallicchio, Lara
    Caporusso, Nicola
    Recchia, Valentina
    Didonna, Luigi
    Pezzuto, Giancarlo
    Pisani, Luigi
    Petruzzellis, Antonella
    Delmonte, Vito
    Tamma, Filippo
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [45] Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury
    Tabassum, Neha
    Zhang, Hua
    Stebbing, Justin
    CELL REPORTS MEDICINE, 2020, 1 (08)
  • [46] A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
    Weiqi Hong
    Jingyun Yang
    Zhenfei Bi
    Cai He
    Hong Lei
    Wenhai Yu
    Yun Yang
    Changfa Fan
    Shuaiyao Lu
    Xiaozhong Peng
    Xiawei Wei
    Signal Transduction and Targeted Therapy, 6
  • [47] SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target
    Federico Giovannoni
    Francisco J. Quintana
    Cell Research, 2021, 31 : 1 - 2
  • [48] SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
    Howell, Mark C.
    Green, Ryan
    McGill, Andrew R.
    Dutta, Rinku
    Mohapatra, Subhra
    Mohapatra, Shyam S.
    CANCERS, 2021, 13 (11)
  • [49] The Potential Impact of Ayurvedic Traditional Bhasma on SARS-CoV-2-Induced Pathogenesis
    Kumar, Pankaj
    Jayakumar, Remya
    Dash, Manoj Kumar
    Joshi, Namrata
    CURRENT TRADITIONAL MEDICINE, 2023, 9 (03) : 28 - 43
  • [50] CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis
    Wu, Jiao
    Chen, Liang
    Qin, Chuan
    Huo, Fei
    Liang, Xue
    Yang, Xu
    Zhang, Kui
    Lin, Peng
    Liu, Jiangning
    Feng, Zhuan
    Zhou, Jiansheng
    Pei, Zhuo
    Wang, Yatao
    Sun, Xiu-Xuan
    Wang, Ke
    Geng, Jiejie
    Zheng, Zhaohui
    Fu, Xianghui
    Liu, Man
    Wang, Qingyi
    Zhang, Zheng
    Bian, Huijie
    Zhu, Ping
    Chen, Zhi-Nan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)